Abstract | BACKGROUND: METHODS: The donor's autologous fresh-frozen plasma rich in factor VIII (FVIII) by treatment with 1-deamino-8-D-arginine vasopressin was prepared before the operation. At induction, 1-deamino-8-D-arginine vasopressin was given to the donor to increase plasma FVIII level. In addition, autologous fresh-frozen plasma containing high FVIII concentrate was infused intraoperatively. The right lobe was harvested from the donor and transplanted orthotopically. The recipient was treated postoperatively with recombinant FVIII and immunosuppressive agents. RESULTS: The donor did not receive recombinant FVIII or allogenic blood during perioperative periods. No bleeding was encountered in the donor perioperatively. The recipient showed a steady increase in FVIII activity postoperatively and was discharged 40 days after transplantation. Ribavirin and interferon-alpha were provided for 3 months postoperatively to prevent potential recurrence of HCV infection. Serum HCV- RNA by RT-PCR became negative after such treatment. CONCLUSIONS:
|
Authors | Kohjiro Horita, Hidetoshi Matsunami, Yasunobu Shimizu, Akira Shimizu, Masaaki Kurimoto, Kohji Suzuki, Toshihisa Tsukadaira, Morio Arai |
Journal | Transplantation
(Transplantation)
Vol. 73
Issue 12
Pg. 1909-12
(Jun 27 2002)
ISSN: 0041-1337 [Print] United States |
PMID | 12131686
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Factor VIII
- Deamino Arginine Vasopressin
|
Topics |
- Deamino Arginine Vasopressin
(therapeutic use)
- Factor VIII
(administration & dosage)
- Hemophilia A
(complications)
- Hepatitis C
(complications)
- Humans
- Liver Cirrhosis
(surgery)
- Liver Transplantation
(methods)
- Male
- Middle Aged
- Tissue Donors
|